Literature DB >> 10669332

Oral transmission of human immunodeficiency virus by infected seminal fluid and milk: a novel mechanism.

S Baron1, J Poast, C J Richardson, D Nguyen, M Cloyd.   

Abstract

Salivary transmission by the 30 million human immunodeficiency virus (HIV) carriers is rare, despite kissing, aerosolization, and dental treatment. The main protective mechanism of saliva is reported to be inactivation of HIV-transmitting leukocytes by its unique hypotonicity; however, the successful oral transmission of HIV by seminal fluid and milk is unexplained. Whether seminal fluid and milk successfully transmit HIV orally by overcoming the recipient's salivary hypotonic inactivation of HIV-transmitting leukocytes was tested. Isotonic salt solution and normal donor samples of milk, colostrum, seminal fluid, and blood were studied for their ability to overcome the salivary hypotonic inactivation. All samples, in physiologic volumes, prevented the hypotonic saliva from inactivating HIV-transmitting leukocytes by providing solutes and retarding diffusion. This indicates that successful oral transmission of HIV by seminal fluid, milk, and colostrum may be due to their isotonicity, which overcomes hypotonic salivary inactivation of HIV-transmitting leukocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669332     DOI: 10.1086/315251

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  10 in total

1.  Inhibition of human immunodeficiency virus type 1 entry by a binding domain of Porphyromonas gingivalis gingipain.

Authors:  Hua Xie; Natalya I Belogortseva; Jie Wu; Wei-Hong Lai; Chin-ho Chen
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  The High Content of Fructose in Human Semen Competitively Inhibits Broad and Potent Antivirals That Target High-Mannose Glycans.

Authors:  Jacklyn Johnson; Manuel G Flores; John Rosa; Changze Han; Alicia M Salvi; Kris A DeMali; Jennifer R Jagnow; Amy Sparks; Hillel Haim
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

3.  Comparison of human immunodeficiency virus type 1-specific inhibitory activities in saliva and other human mucosal fluids.

Authors:  Shamim H Kazmi; Julian R Naglik; Simon P Sweet; Robert W Evans; Siobhan O'Shea; Jangu E Banatvala; Stephen J Challacombe
Journal:  Clin Vaccine Immunol       Date:  2006-08-23

Review 4.  Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection?

Authors:  C W Cutler; R Jotwani
Journal:  Adv Dent Res       Date:  2006-04-01

5.  Proteomic and bioinformatic profile of primary human oral epithelial cells.

Authors:  Santosh K Ghosh; Elizabeth Yohannes; Gurkan Bebek; Aaron Weinberg; Bin Jiang; Belinda Willard; Mark R Chance; Michael T Kinter; Thomas S McCormick
Journal:  J Proteome Res       Date:  2012-10-16       Impact factor: 4.466

6.  Assessment of oral transmission using cell-free human immunodeficiency virus-1 in mice reconstituted with human peripheral blood leucocyte.

Authors:  Ryoma Nakao; Nobuhiro Hanada; Toshihiko Asano; Takashi Hara; Md Abdus Salam; Khairul Matin; Yoshihito Shimazu; Tadashi Nakasone; Shigeo Horibata; Takaaki Aoba; Mitsuo Honda; Teruo Amagasa; Hidenobu Senpuku
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

7.  Pathogenesis of oral FIV infection.

Authors:  Craig Miller; Karen Boegler; Scott Carver; Martha MacMillan; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

Review 8.  Innate antiviral defenses in body fluids and tissues.

Authors:  S Baron; I Singh; A Chopra; D Coppenhaver; J Pan
Journal:  Antiviral Res       Date:  2000-11       Impact factor: 5.970

9.  Oral keratinocytes support non-replicative infection and transfer of harbored HIV-1 to permissive cells.

Authors:  Anjalee Vacharaksa; Anil C Asrani; Kristin H Gebhard; Claudine E Fasching; Rodrigo A Giacaman; Edward N Janoff; Karen F Ross; Mark C Herzberg
Journal:  Retrovirology       Date:  2008-07-17       Impact factor: 4.602

Review 10.  Saliva and viral infections.

Authors:  Paul L A M Corstjens; William R Abrams; Daniel Malamud
Journal:  Periodontol 2000       Date:  2016-02       Impact factor: 7.589

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.